8-KThe WireRoutine
Reg FD Disclosure
Filed Sep 2, 2025 · 10mo ago · Accession 0000950170-25-112345
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- NewAmsterdam Pharma Co N.V.
- Ticker
- NAMS
- CIK
- 1936258
- Form type
- 8-K
- Filing date
- Sep 2, 2025
- Report date
- Sep 2, 2025
- Document
- nams-20250902.htm
- Size
- 17.8 MB